Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension

Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Oct 16, 2022

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical methods for treating pelvic organ prolapse, specifically uterine prolapse. The two methods being compared are transvaginal sacrospinous hysteropexy, which involves fixing the uterus using natural tissue, and laparoscopic uterine lateral suspension, a minimally invasive surgery that uses small incisions and aims for quicker recovery. The goal is to see which method is more effective and safe in the long run, as well as to identify any potential side effects.

To participate in this trial, women over the age of 21 with at least stage 2 uterine prolapse are eligible, even if they have tried other treatments before. Participants should be willing to undergo surgery that preserves the uterus and will need to complete questionnaires about their experience. It’s important to note that women who have had previous surgeries for prolapse or hysterectomies, those with certain medical conditions, or those who are pregnant are not eligible for this trial. Participants can expect to receive careful monitoring and support throughout the study.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • older than 21 years old.
• • uterine prolapse stage 2 at least, defined by C point distal to -1cm by POP-Q system.
• • patients willing to receive a uterine-preserving surgery for pelvic organ prolapse, and is suitable for anesthesia after evaluation.
• • patients who had or had not received conservative treatments for pelvic organ prolapse.
• • patients able and willing to finish the questionnaire evaluation.
• Exclusion Criteria:
• • patient who had received a previous hysterectomy, or is planning on concomitant hysterectomy in the surgery for pelvic organ prolapse.
• • patient who had received a previous surgery for pelvic organ prolapse.
• • patient with history of adverse events following a synthetic mesh.
• • patients with chronic or acute pelvic pain.
• • patients who had received abdominal or pelvic irradiation.
• • patients who cannot receive either surgery due to comorbidity.
• • patients pregnant or with future plan of pregnancy.
• • patients with vaginal length less than 5cm.